Aptose Biosciences Inc. (TSE:APS - Get Free Report) NASDAQ: APTO crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$2.19 and traded as low as C$1.11. Aptose Biosciences shares last traded at C$1.20, with a volume of 6,790 shares.
Aptose Biosciences Stock Up 1.7%
The company has a current ratio of 1.05, a quick ratio of 5.41 and a debt-to-equity ratio of -117.37. The company has a market cap of C$52.10 million, a price-to-earnings ratio of -0.24 and a beta of 1.36. The firm's fifty day simple moving average is C$2.12 and its 200 day simple moving average is C$5.03.
Aptose Biosciences Company Profile
(
Get Free Report)
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Featured Stories
Before you consider Aptose Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aptose Biosciences wasn't on the list.
While Aptose Biosciences currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.